![]() |
市場調査レポート
商品コード
1519388
肩関節形成術の市場レポート:デバイス、手技、適応症、エンドユーザー、地域別、2024~2032年Shoulder Arthroplasty Market Report by Device, Procedure, Indication, End User, and Region 2024-2032 |
||||||
カスタマイズ可能
|
肩関節形成術の市場レポート:デバイス、手技、適応症、エンドユーザー、地域別、2024~2032年 |
出版日: 2024年07月01日
発行: IMARC
ページ情報: 英文 144 Pages
納期: 2~3営業日
|
世界の肩関節形成術の市場規模は2023年に18億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに28億米ドルに達し、2024~2032年の間に5.3%の成長率(CAGR)を示すと予測しています。
肩関節形成術は、病気や損傷した肩のボール&ソケット関節を、金属部品やプラスチックインプラントでできた人工関節に置き換える外科手術です。一般的には、X線試験、血液試験、骨スキャン、身体試験、コンピューター断層撮影(CT)スキャン、磁気共鳴画像(MRI)スキャンなどを用いて患者を徹底的に評価した後に行われます。現在では、一次性変形性関節症、外傷後関節炎、炎症性関節炎、上腕骨近位部骨折、上腕骨頭頸部骨壊死、腱板欠損による偽性麻痺などの治療に用いられています。
炎症性関節炎、関節窩骨壊死、外傷後の退行性関節疾患など、いくつかの疾患が肩の痛みや障害を引き起こし、患者の日常生活に支障をきたすことがあります。従って、このような症状に悩む人の数の大幅な増加は、肩関節形成術の必要性を増大させる重要な要因の1つです。さらに、肩の痛みは加齢とともに増加するため、増加する高齢化人口が、肩関節の可動性と機能を維持するために、肩関節形成術を採用するきっかけとなっています。これとは別に、陸上競技のパフォーマンス中に要求される強い力や反復運動は、肩の深刻な骨折や損傷を引き起こす可能性があります。このことは、プロスポーツへの市場参入企業の増加と相まって、市場にプラスの影響を与えています。さらに、市場の参入企業は、様々な条件下で肩の再建のための豊富な種類のインプラントを提供しています。また、上腕骨頭の表面置換術、解剖学的半関節形成術、肩関節全置換術、逆肩関節形成術、骨折や非結合に対する外傷特異的インプラントなど、幅広い選択肢を持つ最新のインプラントを導入しています。これにより、全体的なシェアが拡大し、今後数年間は市場を牽引すると予想されます。
The global shoulder arthroplasty market size reached US$ 1.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.8 Billion by 2032, exhibiting a growth rate (CAGR) of 5.3% during 2024-2032.
Shoulder arthroplasty is a surgical procedure wherein diseases or damaged ball and socket joints of the shoulder are replaced with a prosthesis made of metal components or plastic implants. It is generally performed after a thorough evaluation of patients using x-rays, blood tests, bone scans, physical examinations, computed tomography (CT) scans, and magnetic resonance imaging (MRI) scans. Presently, it is used to treat individuals with primary osteoarthritis, post-traumatic arthritis, inflammatory arthritis, proximal humeral fractures, osteonecrosis of the humeral head and neck, and pseudo paresis caused by rotator cuff deficiency.
Several conditions, such as inflammatory arthritis, osteonecrosis involving the glenoid and post-traumatic degenerative joint disease, can cause shoulder pain and disability and interfere with the everyday activities of patients. Thus, a significant rise in the number of individuals suffering from these conditions represents one of the key factors augmenting the need for shoulder arthroplasty. Moreover, as shoulder pain increases with age, the growing aging population is catalyzing the adoption of shoulder arthroplasty to preserve their shoulder joint mobility and function. Apart from this, high-force and repetition activities required by athletics during performance can result in severe shoulder fracture or damage. This, in confluence with the increasing participation of individuals in professional sports, is influencing the market positively. Furthermore, market players are offering an extensive array of implants for shoulder reconstruction in different conditions. They are also introducing modern implants with a wide range of options, including resurfacing the humeral head, anatomic hemiarthroplasty, total shoulder arthroplasty, reverse shoulder arthroplasty, and trauma-specific implants for fractures and nonunions. This is anticipated to expand their overall share and drive the market in the coming years.
IMARC Group provides an analysis of the key trends in each sub-segment of the global shoulder arthroplasty market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on device, procedure, indication and end user.
Shoulder Arthroplasty Resurfacing Implants
Shoulder Arthroplasty Trauma Devices
Shoulder Arthroplasty Platform Systems
Partial Shoulder Arthroplasty
Total Shoulder Arthroplasty
Revision Shoulder Arthroplasty
Arthritis
Fracture/Dislocation
Rotator Cuff Tear Arthropathy
Hill Sachs Defect
Others
Hospitals
Orthopedic Centers
Ambulatory Surgical Centers
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Arthrex Inc., BioTek Instruments Inc. (Agilent Technologies Inc.), Conmed Corporation, DJO Global (Colfax Corporation), Exactech Inc., Implantcast GmbH, Integra LifeSciences Corporation, Johnson & Johnson, Kinamed Incorporated, Limacorporate S.p.A., Medacta Group, Smith and Nephew Plc, Stryker Corporation and Zimmer Biomet.